[1] Diel R et al. Tuberculosis: cost of illness in Germany. Eur Respir J 2012; 40: 143–51

[2] Raizada N et al. Feasibility of Decentralised Deployment of XPERT^® MTB/RIF Test at Lower Level of Health System in India. PLoS ONE 2014; 9: e89301

[3] Diel R et al. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals. Eur Respir J 2016; 47: 575–87

[4] Ziegler R et al. Tuberculosis infection control - recommendations of the DZK. Gesundheitswesen 2012; 74: 337–50